PIK3CA and neoplasm: These findings are consistent with the effects of DR on the growth of early tumors due to both systemic changes in the host (e.g., circulating levels of insulin or IGF-1) and signaling events that are intrinsic to the tumor cells (e.g., those involving AMPK, mTOR, or SIRT1, all of which interact with the PI3K pathway at multiple levels).